chr12-6313690-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001384598.1(PLEKHG6):c.200G>A(p.Arg67Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001384598.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PLEKHG6 | NM_001384598.1 | c.200G>A | p.Arg67Gln | missense_variant | 3/16 | ENST00000684764.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PLEKHG6 | ENST00000684764.1 | c.200G>A | p.Arg67Gln | missense_variant | 3/16 | NM_001384598.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250638Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135634
GnomAD4 exome AF: 0.0000602 AC: 88AN: 1461498Hom.: 0 Cov.: 32 AF XY: 0.0000578 AC XY: 42AN XY: 727084
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.200G>A (p.R67Q) alteration is located in exon 3 (coding exon 2) of the PLEKHG6 gene. This alteration results from a G to A substitution at nucleotide position 200, causing the arginine (R) at amino acid position 67 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at